Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
NCT05325073Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Feb 2022
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of erythropoietin in Liver transplant rejection, sponsored by Northwestern University. Started Feb 2022; status: completed.
02
Drugs
erythropoietin
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT05325073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05325073.